VILDAZYME 50

VILDAZYME 50 contains Vildagliptin 50 mg, a DPP-4 inhibitor used in the treatment of type 2 diabetes. It works by improving the body’s natural insulin response after meals and reducing excess glucose production in the liver. VILDAZYME 50 helps maintain better blood sugar control, supports improved HbA1c levels, and is commonly used as part of a long-term diabetes management plan.